Examination of the ocular inflammatory effects after COVID-19 - vaccine

Main Article Content

Ammar Adil Fahad
Basman Radhi Majeed

Keywords

COVID-19, Ocular, Uveitis, Vaccination

Abstract

Background: Recent researches indicated that the ophthalmologic negative impacts of COVID-19 disease and COVID-19 vaccination are highly overlapping. Objective: The present study aimed to investigate the inflammatory side effects after COVID-19 vaccination.
Patients and methods: A total of (60) cases who received two doses of COVID-19 vaccine were included to report ocular side effects appeared within14 days of receiving the second dose.
Results: Uveitis was recorded in (60%) of the study population after COVID-19 vaccinations, while the other inflammatory side effects were distributed as follows; scleritis (15%), VKH (10%), other effects (8.4%) and neuroretinopathy(6.6%). The majority (71.67%) of the study population was treated by corticosteroids. Visual acuity lowered ≤ 3 lines in (25%) of other inflammatory conditions; VA lowered > 3 lines in (25%) of other inflammatory conditions and (5.56%) of uveitis.
Conclusion: Following COVID-19 vaccination, ophthalmologic inflammatory events are possible.

Abstract 230 | pdf Downloads 87

References

1. Bohler AD, Strom ME, Sandvig KU, et al. Acute macular neuroretinopathy following COVID-19 vaccination. Eye (Lond). 2021; 1–2.
2. Cunningham ET, Jr, Moorthy RS. Vaccineassociated posterior uveitis. Retina. 2020; 40(4):595–598.
3. ElSheikh RH , Haseeb A , Eleiwa TK , Elhusseiny AM. Acute Uveitis following COVID-19 Vaccination. Ocul Immunol Inflamm. 2021; 18;
29(6):1207-1209.
4. Gabrielle PH, Baudin F, Ben Ghezala I, et al. Bilateral acute macular neuroretinopathy in a young woman after the first dose of OxfordAstraZeneca COVID-19 vaccine. Am J Ophthalmol Case Rep. 2022; 25:101281. doi:10.1016/j.ajoc.2022.101281
5. Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021; 384:2092–2101.
6. Jampol LM, Tauscher R Schwarz, HCOVID-L 19. COVID-19 vaccinations and subsequent abnormalities in the retina: causation or
coincidence? JAMA Ophthalmol. 2021; 139:1135–1136
7. Maleki A, Look-Why S, Manhapra A, Foster CS. COVID-19 recombinant mRNA vaccines and serious ocular inflammatory side effects: real or
coincidence? Journal of Ophthalmic & Vision Research . 2021; 16(3):490–501.
8. Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following vaccination for COVID-19. Ocul Immunol Inflamm. 2021; 1–2.
9. Ng XL, Betzler BK, Testi I, et al. Ocular Adverse Events After COVID-19 Vaccination. Ocul Immunol Inflamm. 2021; 29(6):1216-1224.
10. Papasavvas I and Herbort Jr . Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. J Ophthalmic Inflamm Infect. 2021; 11:21. doi:10.1186/ s12348-021-00251-5.
11. Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG . Association of Ocular Adverse Events with Inactivated COVID-19 vaccination in
patients in Abu Dhabi. JAMA Ophthalmol 2(10):1131. https://doi.org/10.1001/jama ophthalmol.2021.3477
12. Santovito LS and Pinna G. Acute reduction of visual acuity and visual field after PfizerBioNTech COVID-19 vaccine 2nd dose: a case
report. Inflamm Res. 2021; 70(9):931-933.
13. Saraceno JJF, Souza GM, Dos Santos Finamor LP, et al. Vogt-KoyanagiHarada Syndrome following COVID-19 and ChAdOx1 nCoV-19
(AZD1222) vaccine. Int J Retina Vitreous. 2021; 7:49. doi:10.1186/ s40942-021-00319-3
14. Testi I, Brandão-de-Resende C, Agrawal R, Pavesio C; COVID-19 Vaccination Ocular Inflammatory Events Study Group. Ocular
inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect. 2022; 12(1):4.
15. Watad A, De Marco G, Mahajna H, et al. Immune-Mediated Disease Flares or New- Onset Disease in 27 Subjects Following mRNA/DNA
SARS-CoV-2 Vaccination. Vaccines (Basel) 2021; 9(5):435.
16. ZADEH, Firoozeh Abolhasani, et al. Cytotoxicity evaluation of environmentally friendly synthesis Copper/Zinc bimetallic nanoparticles on MCF-7 cancer cells. Rendiconti Lincei. Scienze Fisiche e Naturali, 2022, 1-7.
17. ROHMAH, Martina Kurnia, et al. Modulatory role of dietary curcumin and resveratrol on growth performance, serum immunity responses,
mucus enzymes activity, antioxidant capacity and serum and mucus biochemicals in the common carp, Cyprinus carpio exposed to abamectin. Fish & Shellfish Immunology, 2022, 129: 221-230.
18. ARIF, Anam, et al. The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer. International Immunopharmacology, 2023, 114: 109581.
19. MARGIANA, Ria, et al. Functions and therapeutic interventions of non-coding RNAs associated with TLR signaling pathway in
atherosclerosis. Cellular Signalling, 2022, 100: 110471.
20. H. A. Al-Hchaimi, M. F. Alhamaidah, H. Alkhfaji, M. T. Qasim, A. H. Al-Nussairi and H. S. Abd-Alzahra, "Intraoperative Fluid Management for Major Neurosurgery: Narrative study," 2022 International Symposium on Multidisciplinary Studies and Innovative
Technologies (ISMSIT), 2022, pp. 311-314, doi: 10.1109/ISMSIT56059.2022.9932659.
21. MOHAMMED, Zainab; QASIM, Maytham T. The Relationship between Insulin Resistance and Hypertension in Patient with Hypertensive. HIV
Nursing, 2022, 22.2: 1659–1663-1659–1663.
22. LEI, Zimeng, et al. Detection of abemaciclib, an anti-breast cancer agent, using a new electrochemical DNA biosensor. Frontiers in
Chemistry, 2022, 10.
23. BASHAR, Bashar S., et al. Application of novel Fe3O4/Zn-metal organic framework magnetic nanostructures as an antimicrobial agent and
magnetic nanocatalyst in the synthesis of heterocyclic compounds. Frontiers in Chemistry, 2022, 10.